|
Gadolinium Lawyers - NSF Lawsuits
Gadolinium has been linked to
nephrogenic systemic fibrosis (NSF) in patients who received gadolinium-based contrast agents. The FDA has asked manufacturers to include a new boxed warning on the product labeling of all gadolinium-based contrast agents which are used to enhance the quality of magnetic resonance imaging (MRI).
The requested warning would state that patients with severe kidney insufficiency who receive gadolinium-based agents are at risk for developing a debilitating, and a potentially fatal disease known as nephrogenic systemic fibrosis (NSF). In addition, it would state that patients just before or just after liver transplantation, or those with chronic liver disease, are also at risk for developing NSF if they are experiencing kidney insufficiency of any severity.
Patients with NSF develop thickening of the skin and connective tissues that inhibits their ability to move and may result in broken bones. Other organs are at risk of thickening as well. The cause of NSF is not known and there is no consistently effective treatment of this condition.
If you have been diagnosed with NSF, please fill out the form below to contact an attorney:
Injured Person Information:
Accident / Injury Information:
Case Description*
Please explain exactly what happened, trying to state
as thoroughly as possible who you believe was responsible
and why you believe that person was negligent:
|
Please explain the full extent of the victims injuries:
|
Comments / Additional Information
Is there anything else that would assist us in
understanding the facts of your case?
|
| 
